← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lawrence Livermore National Security, Llc
Livermore, CA
$20,373,784
Total funding
20
Grants
Funding over time
peak $6.7M · FY2015–25$10M$7.5M$5M$2.5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,565,419 · 18
NASA$808,365 · 2
By mechanism
R24$6,490,542 · 1
R01$4,789,568 · 1
U19$3,925,979 · 12
R61$1,959,854 · 1
R33$1,766,629 · 1
—$808,365 · 2
Investigators at Lawrence Livermore National Security, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis$1,916,780
U19 · FY2022 · AI
Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis$1,878,172
U19 · FY2023 · AI
National User Resource for Biological Accelerator Mass Spectrometry$1,406,025
R24 · FY2020 · GM
National User Resource for Biological Accelerator Mass Spectrometry$1,218,873
R24 · FY2021 · GM
National User Resource for Biological Accelerator Mass Spectrometry$1,206,711
R24 · FY2024 · GM
National User Resource for Biological Accelerator Mass Spectrometry$1,206,711
R24 · FY2023 · GM
National User Resource for Biological Accelerator Mass Spectrometry$1,206,711
R24 · FY2022 · GM
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology$981,821
R61 · FY2021 · HL
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology$978,033
R61 · FY2022 · HL
INTERNATIONAL SPACE STATION MICROBIAL OBSERVATORY OF PATHOGENIC VIRUS BACTERIA AND FUNGI (ISS-MOP) PROJECT WILL GENERATE THE MICROBIAL CENSUSES ASSOCIATED WITH VARIOUS ISS MODULES USING TRADITIONAL CULTURE-BASED METHODS AND STATE-OF-THE ART MOLECULAR TECHNIQUES. THE OBJECTIVES OF THE ISS-MOP PROJECT ARE TO MEASURE PRESENCE OF VIRAL AND SELECT BACTERIAL AND FUNGAL PATHOGENS AND CORRELATE THEIR PRESENCE ON CREW. THE EFFECTS OF THE SPACEFLIGHT ENVIRONMENT ON VIRAL AND MICROBIAL PATHOGEN DYNAMICS ARE LARGELY UNKNOWN AND REPRESENT BOTH A SIGNIFICANT GAP IN OUR KNOWLEDGE AND AN IMPORTANT OPPORTUNITY TO STUDY THE PRESENCE OF MICROBIAL POPULATIONS AND PREDICT HEALTH RISKS DURING LONG-TERM SPACE EXPLORATION. THE HYPOTHESIS OF THE ISS-MOP PROJECT IS THAT CERTAIN SHORT-LIVING VIRUSES ASSOCIATED WITH INERT ENVIRONMENTAL SPACES IN THE CLOSED HABITAT OF THE ISS CAN HAVE AN ADVERSE INFLUENCE ON CREW HEALTH. TO TEST THIS HYPOTHESIS THE TEAM WILL CATALOGUE VIRUSES ASSOCIATED WITH SURFACES AND AIR OF THE ISS MODULES USING THE ALL-ENCOMPASSING LAWRENCE LIVERMORE MICROBIAL DETECTION ARRAY (LLMDA) WHICH CONTAINS PROBES TO DETECT NOT ONLY VIRUSES BUT ALSO CLINICALLY IMPORTANT HUMAN BACTERIAL AND FUNGAL PATHOGENS. IN ADDITION SKIN AND SALIVA SAMPLES FROM CREWMEMBERS WILL BE REQUESTED TO TEST THE HYPOTHESIS. THERE ARE THREE AIMS PROPOSED IN THIS ISS-MOP PROJECT. WHILE THE CULTIVATION-BASED ASSAY (AIM 1) PROVIDES A VALID ESTIMATION OF MICROBIAL PRESENCE IT OFFERS ONLY A LIMITED ASSESSMENT OF THE PHYLOGENETIC/PATHOGENIC DIVERSITY AND PHYSIOLOGICAL BREADTH OF THE MICROBIAL POPULATION PRESENT. THEREFORE THE TEAM WILL USE THE NOVEL AND COMPREHENSIVE LLMDA MICROARRAY THAT IS SPECIFICALLY DESIGNED TO ELUCIDATE THE PATHOGENIC VIRAL AND MICROBIAL DIVERSITY PROFILES OF COMPLEX SAMPLES TO AT LEAST THE SPECIES LEVEL (AIM 2). IN ADDITION WE WILL CHARACTERIZE THE VIRULENCE AND ANTIBIOTIC RESISTANCE MECHANISMS ASSOCIATED WITH THESE PATHOGENS FROM THE ISS BY DEVELOPING A NEW VIRULENCE AND ANTIBIOTIC RESISTANCE GENE ARRAY AND ANALYZE THE SAMPLES ON THIS ARRAY. THE FINAL DELIVERABLE OF THE PROPOSED PROJECT TO NASA WILL BE THE ISS-MOP DATASET A COMPILATION OF ALL OF THE GENOMIC SEQUENCES AND GENETIC INFORMATION OF VIRUSES AND MICROBES ENCOUNTERED ON AND WITHIN THE ISS HABITAT (AIM 3).$613,747
· FY2020 · National Aeronautics and Space Administration
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology$608,177
R33 · FY2023 · HL
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology$588,081
R33 · FY2025 · HL
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology$570,371
R33 · FY2024 · HL
Technology development for biological imaging with x-ray free electron lasers$541,329
R01 · FY2020 · GM
Technology development for biological imaging with x-ray free electron lasers$536,721
R01 · FY2019 · GM
Technology development for biological imaging with x-ray free electron lasers$535,786
R01 · FY2018 · GM
Technology development for biological imaging with x-ray free electron lasers$533,280
R01 · FY2016 · GM
Technology Development for Biological Imaging with XFELs$532,873
R01 · FY2021 · GM
Technology development for biological imaging with x-ray free electron lasers$532,205
R01 · FY2017 · GM
Project 1. Nanolipoprotein-supported multi-subunit vaccine for Chlamydia trachomatis$530,606
U19 · FY2022 · AI